Sugi Predict

Sugi Predict / Compounds / SCHEMBL20064206

SCHEMBL20064206

SCHEMBL20064206

Cc1cc2ccccc2c2c1sc1c(-c3cccc(-c4cccc(-c5nc(-c6ccccc6)nc(-c6ccccc6)n5)c4)c3)cccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 3/20 0.36
▸ LIMK1 P53667 1/20 0.36
▸ MAPT P10636 4/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ TDO2 P48775 1/20 0.35
▸ MAPK1 P28482 3/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ HSD17B10 Q99714 2/20 0.35
▸ HPGD P15428 2/20 0.35
▸ ATM Q13315 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ NFKB1 P19838 1/20 0.35
▸ NFKB2 Q00653 1/20 0.35
▸ RELA Q04206 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20064201 0.88 LIMK1 (0.40) L3MBTL1LIMK1MAPTMEN1KMT2A
SCHEMBL21157053 0.87 LIMK1 (0.39) L3MBTL1LIMK1MAPTMEN1KMT2A
SCHEMBL23348348 0.87 LIMK1 (0.43) L3MBTL1LIMK1MAPTMEN1KMT2A
SCHEMBL20064197 0.85 ALDH1A1 (0.40) L3MBTL1LIMK1MAPTMEN1KMT2A
SCHEMBL20064208 0.85 LIMK1 (0.39) L3MBTL1LIMK1MAPTMEN1KMT2A
SCHEMBL19916891 0.83 LIMK1 (0.40) L3MBTL1LIMK1MAPTMEN1KMT2A
SCHEMBL17425579 0.83 LIMK1 (0.43) L3MBTL1LIMK1MAPTMEN1KMT2A
SCHEMBL17425511 0.83 LIMK1 (0.47) L3MBTL1LIMK1MAPTMEN1KMT2A
SCHEMBL30022468 0.83 LIMK1 (0.43) L3MBTL1LIMK1MAPTMEN1KMT2A
SCHEMBL17425729 0.83 LIMK1 (0.43) L3MBTL1LIMK1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10741769-B2 Organic compound, light-emitting element, light-emitting device, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2020-08-11 — — US disclosed
US-20180108847-A1 Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2018-04-19 — — US disclosed
US-20180108847-A1 Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2018-04-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180108847-A1 Organic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device NR2E3, NR0B1, NR2E1 L3MBTL1 424/4885LIMK1 1622/4885MAPT 3286/4885
US-10741769-B2 Organic compound, light-emitting element, light-emitting device, electronic device, and lighting device NR2E3, NR0B1, NR2E1 L3MBTL1 424/4885LIMK1 1622/4885MAPT 3286/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.